Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the efficacy and safety of Envafolimab in combination with Cetuximab and the mFOLFOX6 regimen in patients with MSS, RAS/BR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Envafolimab (envafolimab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING